RESUMO
Lack of suitable surface properties in biomaterials is an acute challenge for their utilization in nucleic acid delivery, since surface plays a vital role in cell adhesion/uptake and immunity. Low pressure cold plasma is a promising technology for functionalization and surface modification of materials, in an effective, environment friendly and economical way. In this investigation we have modified the surface of silver nanoparticles (AgNPs) with chitosan biopolymer, using plasma treatment, to extend their application scope in intracellular DNA delivery. The plasma functionalized; chitosan modified AgNPs (MetaloPolymeric Nanocarriers; MPNCs) possessed superior biocompatibility compared to unmodified AgNPs. Carboxylic groups were incorporated on the surface of nanosilver using 3600 rotating pulsed plasma reactor and acrylic acid vapors were used as precursor gas. Pulsed plasma polymerization process was optimized with respect to working pressure of the system, duty cycle for pulsing, time of treatment and flow rate. Biocompatibility of the plasma functionalized nanosilver was enhanced by coupling it with Chitosan Oligosaccharide (COS), using EDC (1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide) to form amide linkages. The resulting MPNCs showed high cell viability and bio-stability, which was attributed to plasma processing of nanosilver and its association with COS. In vitro cellular studies illustrated significant uptake of nanoplexes. The study suggested the potential of plasma functionalization for manipulating surfaces of metallic nanoparticles to enhance their application in intracellular gene delivery.
